2023
The association of catestatin and endocan with the effects of cardiac shock wave therapy: Biomarker sub-study of the randomized, sham procedure-controlled trial
Burneikaitė G, Shkolnik E, Puronaitė R, Zuozienė G, Petrauskienė B, Misonis N, Kazėnaitė E, Laucevičius A, Smih F, Rouet P, Čelutkienė J. The association of catestatin and endocan with the effects of cardiac shock wave therapy: Biomarker sub-study of the randomized, sham procedure-controlled trial. Frontiers In Cardiovascular Medicine 2023, 10: 1004574. PMID: 36910537, PMCID: PMC9996196, DOI: 10.3389/fcvm.2023.1004574.Peer-Reviewed Original ResearchCardiac shock wave therapyEndocan levelsShock wave therapyMyocardial perfusionContractile functionCoronary collateral developmentWhole study populationWall motion scorePotential predictive valueAssociation of increasesAvailable ELISA kitsCatestatin concentrationsDobutamine echocardiographyStable anginaEndocan concentrationsRevascularization proceduresCatestatin levelsMyocardial scintigraphyCollateral developmentWave therapyInclusion criteriaMotion scoreStudy populationBlood samplesPredictive value
2022
Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy: 3-Year Results of the SUCCOUR Trial.
Negishi T, Thavendiranathan P, Penicka M, Lemieux J, Murbraech K, Miyazaki S, Shirazi M, Santoro C, Cho GY, Popescu BA, Kosmala W, Costello B, la Gerche A, Mottram P, Thomas L, Seldrum S, Hristova K, Bansal M, Kurosawa K, Fukuda N, Yamada H, Izumo M, Tajiri K, Sinski M, Vinereanu D, Shkolnik E, Banchs J, Kutty S, Negishi K, Marwick TH. Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy: 3-Year Results of the SUCCOUR Trial. JACC Cardiovasc Imaging 2022 PMID: 36435732, DOI: 10.1016/j.jcmg.2022.10.010.Peer-Reviewed Original Research
2021
Corrigendum to : One clot after another in COVID-19 patient: diagnostic utility of handheld echocardiogram
Jeyashanmugaraja GP, Shkolnik E, Akanya DT, Stawiarski K, Winterbottom C, Zarich S. Corrigendum to : One clot after another in COVID-19 patient: diagnostic utility of handheld echocardiogram. Oxford Medical Case Reports 2021, 2021: omab070. PMID: 34327007, PMCID: PMC8315121, DOI: 10.1093/omcr/omab070.Peer-Reviewed Original Research
2019
The effect of cardiac shock wave therapy on myocardial function and perfusion in the randomized, triple-blind, sham-procedure controlled study.
Čelutkienė J, Burneikaitė G, Shkolnik E, Jakutis G, Vajauskas D, Čerlinskaitė K, Zuozienė G, Petrauskienė B, Puronaitė R, Komiagienė R, Butkuvienė I, Steponėnienė R, Misiūra J, Laucevičius A. The effect of cardiac shock wave therapy on myocardial function and perfusion in the randomized, triple-blind, sham-procedure controlled study. Cardiovascular Ultrasound 2019, 17: 13. PMID: 31272465, PMCID: PMC6610956, DOI: 10.1186/s12947-019-0163-1.Peer-Reviewed Original Research
2018
A randomized, triple-blind trial of cardiac shock-wave therapy on exercise tolerance and symptoms in patients with stable angina pectoris.
Shkolnik E, Burneikaite G, Jakutis G, Scherbak M, Zuoziene G, Petrauskiene B, Trush E, Vasyuk Y, Laucevicius A, Celutkiene J. A randomized, triple-blind trial of cardiac shock-wave therapy on exercise tolerance and symptoms in patients with stable angina pectoris. Coronary Artery Disease 2018, 29: 579-586. PMID: 29912782, DOI: 10.1097/MCA.0000000000000648.Peer-Reviewed Original ResearchEfficacy of cardiac shock wave therapy in patients with stable angina: The design of randomized, triple blind, sham-procedure controlled study
Shkolnik E, Burneikaite G, Celutkiene J, Scherbak M, Zuoziene G, Petrauskiene B, Trush E, Laucevicius A, Vasyuk Y. Efficacy of cardiac shock wave therapy in patients with stable angina: The design of randomized, triple blind, sham-procedure controlled study. The Anatolian Journal Of Cardiology 2018, 19: 100-109. PMID: 29424731, PMCID: PMC5864803, DOI: 10.14744/anatoljcardiol.2017.8023.Peer-Reviewed Original ResearchConceptsCardiac shock wave therapyOptimal medical treatmentExercise treadmill testShock wave therapyQuality of lifeMyocardial ischemiaAngina symptomsStable anginaWave therapyCanadian Cardiovascular Society class IIISeattle Angina Questionnaire scoresStress-induced myocardial ischemiaCardiac magnetic resonance imagingTreatment 4 weeksTotal exercise durationDobutamine stress echocardiographySingle-center studyCoronary artery diseaseMagnetic resonance imagingStimulation of angiogenesisSingle photon emissionAngina classCentralized randomizationStable dosesExercise tolerance
2017
Cardiac shock-wave therapy in the treatment of coronary artery disease: systematic review and meta-analysis
Burneikaitė G, Shkolnik E, Čelutkienė J, Zuozienė G, Butkuvienė I, Petrauskienė B, Šerpytis P, Laucevičius A, Lerman A. Cardiac shock-wave therapy in the treatment of coronary artery disease: systematic review and meta-analysis. Cardiovascular Ultrasound 2017, 15: 11. PMID: 28403861, PMCID: PMC5389112, DOI: 10.1186/s12947-017-0102-y.Peer-Reviewed Original ResearchConceptsCoronary artery diseaseExercise capacityArtery diseaseEnd-stage coronary artery diseaseCochrane Controlled Trials RegisterStable coronary artery diseaseSeattle Angina Questionnaire scoresCardiac shock wave therapyAnti-anginal efficacyControlled Trials RegisterDouble-blind studySingle-center studySingle-arm studyShock wave therapyLarger patient samplesQuality of lifeRandom-effects modelNon-invasive optionAngina classAngina symptomsStable anginaTrials RegisterVentricular functionRandomized trialsArm study[Possibilities of modern echocardiographic technologies in the early diagnosis of the cardiotoxic effect of chemotherapy drugs anthracycline series in cancer patients].
Vasyuk YA, Nesvetov VV, SHkolnik EL, Fursov SA, Shkolnik LD, Gendlin GE, Emelina EI. [Possibilities of modern echocardiographic technologies in the early diagnosis of the cardiotoxic effect of chemotherapy drugs anthracycline series in cancer patients]. Kardiologiia 2017, 57: 31-37. PMID: 29466180, DOI: 10.18087/cardio.2417.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2016
[Cardiooncology: Current Aspects of Prevention of Anthracycline Toxicity].
Vasyuk YA, Shkolnik EL, Nesterov VV, Shkolnik LD, Varlan GV. [Cardiooncology: Current Aspects of Prevention of Anthracycline Toxicity]. Kardiologiia 2016, 56: 72-79. PMID: 28290807.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2012
[Relationship between the structure-functional state of the heart and brain natriuretic peptide level in patients with arterial hypertension].
Vasiuk IuA, Khadzegova AB, Ivanova SV, Iushchuk EN, Shkol'nik EL, Gabitova RG, Sinitsyna IA, Matveeva OS. [Relationship between the structure-functional state of the heart and brain natriuretic peptide level in patients with arterial hypertension]. Kardiologiia 2012, 52: 19-23. PMID: 22839665.Peer-Reviewed Original Research
2011
[The (PRIMA) Study. Comparison of clinical effect of trimetazidine MR in men and women].
Vasiuk IuA, Shal'nova SA, Shkol'nik EL, Kulikov KG. [The (PRIMA) Study. Comparison of clinical effect of trimetazidine MR in men and women]. Kardiologiia 2011, 51: 11-5. PMID: 21878064.Peer-Reviewed Original Research
2010
Initial clinical experience with extracorporeal shock wave therapy in treatment of ischemic heart failure.
Vasyuk YA, Hadzegova AB, Shkolnik EL, Kopeleva MV, Krikunova OV, Iouchtchouk EN, Aronova EM, Ivanova SV. Initial clinical experience with extracorporeal shock wave therapy in treatment of ischemic heart failure. Congestive Heart Failure (Greenwich, Conn.) 2010, 16: 226-30. PMID: 20887620, DOI: 10.1111/j.1751-7133.2010.00182.x.Peer-Reviewed Original Research[Possibilities of if channels inhibitor ivabradine in complex treatment of survivors of myocardial infarction with stable angina].
Vasiuk IuA, Shkol'nik EL, Lebedev EV. [Possibilities of if channels inhibitor ivabradine in complex treatment of survivors of myocardial infarction with stable angina]. Kardiologiia 2010, 50: 13-8. PMID: 20831042.Peer-Reviewed Original Research[Effect of therapy with trimetazidine modified release on quality of life of patients with stable effort angina survivors after acute myocardial infarction. Results of PRIMA study].
Vasiuk YA, Shkol'nik EL, Kudriakov ON, Kulikov KG. [Effect of therapy with trimetazidine modified release on quality of life of patients with stable effort angina survivors after acute myocardial infarction. Results of PRIMA study]. Kardiologiia 2010, 50: 45-9. PMID: 20459421.Peer-Reviewed Original Research
2008
[The PRIMA study: trimetazidin in the treatment of patients with stable angina pectoris after myocardial infarction. Epidemiological and clinical phases].
Vasiuk IuA, Shal'nova SA, Shkol'nik EL, Kulikov KG. [The PRIMA study: trimetazidin in the treatment of patients with stable angina pectoris after myocardial infarction. Epidemiological and clinical phases]. Kardiologiia 2008, 48: 10-3. PMID: 19076088.Peer-Reviewed Original Research
2007
[Shock-wave therapy: novel direction in the treatment of ischemic heart disease].
Khadzegova AB, Shkol'nik EL, Kopeleva MV, Iushchuk EN, Lebedev EV, Vasiuk IuA. [Shock-wave therapy: novel direction in the treatment of ischemic heart disease]. Kardiologiia 2007, 47: 90-4. PMID: 18260970.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements[Chronic low cardiac output and depression (review)].
Vasiuk IuA, Dovzhenko TV, Shkol'nik EL. [Chronic low cardiac output and depression (review)]. Ter Arkh 2007, 79: 54-60. PMID: 18154147.Peer-Reviewed Original Research[Comparative trial of efficacy of trimethasidine MB and 3-(2,2,2-trimethylhydrasine) propionate dihydrate in chronic heart failure].
Vasiuk IuA, Iushchuk EN, Shkol'nik EL, Khadzegova AB, Sadulaeva IA, Vit'ko NK, Vakhromeeva MN. [Comparative trial of efficacy of trimethasidine MB and 3-(2,2,2-trimethylhydrasine) propionate dihydrate in chronic heart failure]. Ter Arkh 2007, 79: 51-8. PMID: 17460970.Peer-Reviewed Original Research